Theresa K. Musser

An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis

Michael E. Weinblatt, Arthur Kavanaugh, Mark C. Genovese et al. · New England Journal of Medicine · 2010 · 377 citations

Medicine, Pharmacology, Pharmacotherapy +15

Treatment of rheumatoid arthritis with a syk kinase inhibitor: A twelve‐week, randomized, placebo‐controlled trial

Michael E. Weinblatt, Arthur Kavanaugh, Rubén Burgos‐Vargas et al. · Arthritis & Rheumatism · 2008 · 336 citations

Medicine, Immunology, Pharmacology +12

Effects of Fostamatinib (R788), an Oral Spleen Tyrosine Kinase Inhibitor, on Health-related Quality of Life in Patients with Active Rheumatoid Arthritis: Analyses of Patient-reported Outcomes from a Randomized, Double-blind, Placebo-controlled Trial

Michael E. Weinblatt, Arthur Kavanaugh, Mark C. Genovese et al. · The Journal of Rheumatology · 2013 · 44 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Effect of retinoids on the induction of colon cancer in F344 rats by N-methyl-N-nitrosourea or by 1,2-dimethyihydrazine

Jerald Silverman, Shoichi Katayama, Kenneth Zelenakes et al. · Carcinogenesis · 1981 · 38 citations

Medicine, Oncology, Pharmacology +11